| pubmed-article:9609356 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9609356 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:9609356 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:9609356 | lifeskim:mentions | umls-concept:C0015688 | lld:lifeskim |
| pubmed-article:9609356 | lifeskim:mentions | umls-concept:C0699748 | lld:lifeskim |
| pubmed-article:9609356 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9609356 | pubmed:dateCreated | 1998-7-16 | lld:pubmed |
| pubmed-article:9609356 | pubmed:abstractText | Over 30 years after the original description of Randle's cycle, the mechanisms by which elevated circulating non-esterified fatty acids might be causally related to glucose intolerance in Type 2 diabetes mellitus remain uncertain. This review examines the evidence that elevated plasma NEFA can inhibit glucose-stimulated insulin secretion by pancreatic beta-cells and impair glucose- and insulin-stimulated glucose disposal by peripheral tissues. Experimental evidence beginning to examine the mechanisms of these phenomena is discussed. | lld:pubmed |
| pubmed-article:9609356 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9609356 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9609356 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9609356 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9609356 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9609356 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9609356 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9609356 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9609356 | pubmed:month | May | lld:pubmed |
| pubmed-article:9609356 | pubmed:issn | 0742-3071 | lld:pubmed |
| pubmed-article:9609356 | pubmed:author | pubmed-author:HowardB VBV | lld:pubmed |
| pubmed-article:9609356 | pubmed:author | pubmed-author:PaolissoGG | lld:pubmed |
| pubmed-article:9609356 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9609356 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:9609356 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9609356 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9609356 | pubmed:pagination | 360-6 | lld:pubmed |
| pubmed-article:9609356 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9609356 | pubmed:meshHeading | pubmed-meshheading:9609356-... | lld:pubmed |
| pubmed-article:9609356 | pubmed:meshHeading | pubmed-meshheading:9609356-... | lld:pubmed |
| pubmed-article:9609356 | pubmed:meshHeading | pubmed-meshheading:9609356-... | lld:pubmed |
| pubmed-article:9609356 | pubmed:meshHeading | pubmed-meshheading:9609356-... | lld:pubmed |
| pubmed-article:9609356 | pubmed:meshHeading | pubmed-meshheading:9609356-... | lld:pubmed |
| pubmed-article:9609356 | pubmed:meshHeading | pubmed-meshheading:9609356-... | lld:pubmed |
| pubmed-article:9609356 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9609356 | pubmed:articleTitle | Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus. | lld:pubmed |
| pubmed-article:9609356 | pubmed:affiliation | Department of Geriatric Medicine and Metabolic Diseases, II University of Naples, Italy. | lld:pubmed |
| pubmed-article:9609356 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9609356 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9609356 | lld:pubmed |
